Match tier Likely match
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-01

Arnav Lakkimsetti

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Role not yet determined Is this you? Add your title

2 pubs

Biography and Research Information

OverviewAI-generated summary

Arnav Lakkimsetti's research focuses on the comparative analysis of targeted therapies in B-cell malignancies. Their work includes a study comparing the mortality and toxicity of ibrutinib, acalabrutinib, and zanubrutinib in real-world settings for patients with these blood cancers. This research aims to provide insights into the comparative effectiveness and safety profiles of these medications.

Metrics

  • Publications: 2

Selected Publications

  • POSTER: CLL-1382: Comparing Ibrutinib With Acalabrutinib and Zanubrutinib in B-Cell Malignancies: A Real-World Study of Mortality and Toxicity (2026)
    Clinical Lymphoma Myeloma & Leukemia DOI OpenAlex
  • CLL-1382: Comparing Ibrutinib With Acalabrutinib and Zanubrutinib in B-Cell Malignancies: A Real-World Study of Mortality and Toxicity (2026)
    Clinical Lymphoma Myeloma & Leukemia DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

7 Collaborators 1 Institution 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics